Skip to main content
Clinical Trials/IRCT20200803048289N1
IRCT20200803048289N1RecruitingPhase 2

Investigation of the effect of of photodynamic therapy with methylene blue on the treatment of cutaneous leishmaniosis

Mashhad University of Medical Sciences0 sites8 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
8

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
4 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Newly diagnosed localized cutaneous leishmaniasis confirmed by smear Giemsa sample
  • Less than 12 weeks has elapsed since the onset of the lesion
  • No lesion on face
  • Number of lesions is less than four
  • No sporotricoid form
  • Size of lesion is less than 5 centimeters
  • The lesion is not on joints.
  • Urban leishmaniasis (based on patient's clinical observations and regional epidemiology)

Exclusion Criteria

  • Pregnancy and breastfeeding
  • Existence of serious or severe underlying diseases (such as heart disease, kidney disease, liver disease, immunodeficiency)

Investigators

Similar Trials